Cardioprotective Activity of Ethanolic Extract of Terminalia arjuna in Isoproterenol-Induced Rats

Main Article Content

Dr. Ch. Maheshwara Reddy
Dr M. Balaji Yadav
G. Indira Priya Darshini
Dr. K. Mangulal

Abstract

One of the main reasons for the high mortality rate worldwide is myocardial infarction (MI). We describe how Partharishtam, an
Ayurvedic polyherbal formulation, protects albino rats against myoproterenol-induced myocardial infarction. Significant alterations in
important biomolecules measured in blood serum and cardiac tissues indicate that isoproterenol causes MI in normal albino rats. In
terms of some of the known identifying markers of MI, including Troponin I and T, creatine phosphokinase serum (CPK-S), creatine
phosphokinase myoglobulin isozyme fraction (CPK-MB), and oxidative enzymes like superoxide dismutase (SOD), reduced glutathione
(GSH), and catalase, the cardioprotective effects of Partharishtam and the standard medication Propranolol were compared. Troponin 1
and T, CPK-S, and CPK-MB levels significantly decreased in isoproterenol-induced MI rats after partharishtam therapy. Studies using in
vivo antioxidant enzymes also showed that when Partharishtam was administered to MI rats, the levels of SOD, GSH, and catalase
increased to almost normal levels. This is quite similar to the widely used medication Propranolol, which is used to treat MI humans. In
a rat model, histopathological research validated Partharistham's cardioprotective qualities. When Partharishtam was tested on healthy
rats, we found no toxicity or adverse effects. Partharishtam, a polyherbal compound, may thus be regarded as a safe medication for
MI. Key words: creatine phosphokinase, SOD, GSH, catalase, partharishtam, polyherbal, isoproterenol, propranolol, troponin I, troponin
T, and myocardial infarction.

Article Details

Section
Articles